DOW JONES27,963.21-1029.20 -3.55%
S&P 5003,221.07-116.68 -3.50%
NASDAQ9,191.68-384.91 -4.02%

Guggenheim Initiates Coverage On Arcturus Therapeutics with Buy Rating, Announces $19 Price Target

Guggenheim analyst Whitney Ijem initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating and a $19 price target.

Benzinga · 02/07/2020 09:45

Guggenheim analyst Whitney Ijem initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating and a $19 price target.